Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Cognition Therapeutics Reports Year End 2022 Financial Results and Provides Business Update
-
Cognition Therapeutics Announces Closing of Public Offering
-
Cognition Therapeutics Announces Closing of Public Offering
-
Cognition Therapeutics, Inc. (CGTX) Prices 5M Share Offering at $1.20/sh
-
Cognition Therapeutics Announces Pricing of Public Offering
-
Cognition Therapeutics Announces Pricing of Public Offering
-
Cognition Therapeutics to Participate in the 2022 Cantor Fitzgerald Neurology & Psychiatry Conference
-
Cognition Therapeutics to Participate in the 2022 Cantor Fitzgerald Neurology & Psychiatry Conference
-
UPDATE: Cantor Fitzgerald Starts Cognition Therapeutics (CGTX) at Overweight
